colforsin has been researched along with cilomilast in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ammit, AJ; Amrani, Y; Hay, DW; Hoffman, RK; Lazaar, AL; Panettieri, RA; Penn, RB; Torphy, TJ | 1 |
Ezeamuzie, CI | 1 |
2 other study(ies) available for colforsin and cilomilast
Article | Year |
---|---|
Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Bucladesine; Cells, Cultured; Chemokine CCL5; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dinoprostone; Dose-Response Relationship, Drug; Humans; Interleukin-6; Muscle, Smooth; NF-kappa B; Nitriles; Phosphodiesterase Inhibitors; RNA, Messenger; Time Factors; Trachea; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2000 |
Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Adult; Albuterol; Benzamides; Cell Degranulation; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Eosinophil Peroxidase; Eosinophils; Histamine; Humans; Nitriles; Peroxidases; Phosphodiesterase Inhibitors; Pyridines; Rolipram; Superoxides; Theophylline | 2001 |